You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Original Contributions Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients: RIO-North America: A Randomized Controlled Trial
F. Xavier Pi-Sunyer; Louis J. Aronne; Hassan M. Heshmati; Jeanne Devin; Julio Rosenstock; for the RIO-North America Study Group
JAMA 2006; 295: 761-775.
[Abstract][Full text][PDF]
Editorials Obesity ResearchLimitations of Methods, Measurements, and Medications
Denise G. Simons-Morton; Eva Obarzanek; Jeffrey A. Cutler
JAMA 2006; 295: 826-828.
[Extract][Full text][PDF]
Perspectives on Care at the Close of Life Meeting Palliative Care Needs in PostAcute Care Settings: "To Help Them Live Until They Die"